CN103816361A - 预防治疗禽流感的中药及其制备方法 - Google Patents
预防治疗禽流感的中药及其制备方法 Download PDFInfo
- Publication number
- CN103816361A CN103816361A CN201410041713.2A CN201410041713A CN103816361A CN 103816361 A CN103816361 A CN 103816361A CN 201410041713 A CN201410041713 A CN 201410041713A CN 103816361 A CN103816361 A CN 103816361A
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- parts
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 206010064097 avian influenza Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 208000002979 Influenza in Birds Diseases 0.000 title abstract description 12
- 230000003405 preventing effect Effects 0.000 title abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 113
- 239000010231 banlangen Substances 0.000 claims abstract description 56
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 55
- 241000951473 Schizonepeta Species 0.000 claims abstract description 49
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 241000628997 Flos Species 0.000 claims description 112
- 241000245240 Lonicera Species 0.000 claims description 48
- 241001529739 Prunella <angiosperm> Species 0.000 claims description 48
- 241000545442 Radix Species 0.000 claims description 48
- 241000207929 Scutellaria Species 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 238000011321 prophylaxis Methods 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 3
- 238000007667 floating Methods 0.000 claims description 3
- 239000008155 medical solution Substances 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 42
- 210000004185 liver Anatomy 0.000 abstract description 24
- 238000011282 treatment Methods 0.000 abstract description 16
- 210000003734 kidney Anatomy 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 8
- 244000144977 poultry Species 0.000 abstract description 7
- 231100000419 toxicity Toxicity 0.000 abstract description 6
- 230000001988 toxicity Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 abstract 1
- 241001660870 Cyrtomium Species 0.000 abstract 1
- 241000244987 Daiswa polyphylla Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 241000555712 Forsythia Species 0.000 description 47
- 241000700605 Viruses Species 0.000 description 20
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 241000271566 Aves Species 0.000 description 15
- 230000003110 anti-inflammatory effect Effects 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 206010011224 Cough Diseases 0.000 description 14
- 239000003440 toxic substance Substances 0.000 description 14
- 229940079593 drug Drugs 0.000 description 13
- 230000000844 anti-bacterial effect Effects 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 241000287828 Gallus gallus Species 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 230000001717 pathogenic effect Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 241000272525 Anas platyrhynchos Species 0.000 description 9
- 235000013330 chicken meat Nutrition 0.000 description 8
- 208000001848 dysentery Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 241001473385 H5N1 subtype Species 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000006454 hepatitis Diseases 0.000 description 6
- 235000013594 poultry meat Nutrition 0.000 description 6
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 5
- 208000004429 Bacillary Dysentery Diseases 0.000 description 5
- 206010052369 Encephalitis lethargica Diseases 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 201000007100 Pharyngitis Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 231100000283 hepatitis Toxicity 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 201000005113 shigellosis Diseases 0.000 description 5
- 201000002498 viral encephalitis Diseases 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 201000000297 Erysipelas Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010035664 Pneumonia Diseases 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000000954 anitussive effect Effects 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000009849 deactivation Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 206010022000 influenza Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 3
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 3
- 241000272814 Anser sp. Species 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 241000712431 Influenza A virus Species 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000005647 Mumps Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000002155 anti-virotic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- 206010014599 encephalitis Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 230000002443 hepatoprotective effect Effects 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 208000010805 mumps infectious disease Diseases 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 206010044008 tonsillitis Diseases 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 206010031252 Osteomyelitis Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- -1 luteolin glycosides Chemical class 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 241000272522 Anas Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016029 Face oedema Diseases 0.000 description 1
- 241000272496 Galliformes Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241000288140 Gruiformes Species 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000776 anti-sterility effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 210000000051 wattle Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
患病分类 | 病例总数 | 痊愈例数 | 有效例数 | 无效例数 | 有效率 |
患病肉鸡 | 483 | 448 | 23 | 12 | 97.52% |
患病蛋鸡 | 562 | 520 | 27 | 15 | 97.33% |
患病鸭 | 685 | 660 | 16 | 9 | 98.69% |
合计 | 1730 | 1628 | 66 | 36 | 97.92% |
分组 | 灭活浓度 | 治疗浓度 | 预防浓度 | 对病毒抑制作用 |
上述中药 | 24.86mg/ml | 35.68mg/ml | 72.35mg/ml | 强 |
对照组1 | 33.37mg/ml | 46.85mg/ml | 125mg/ml | 中 |
对照组2 | 30.52 mg/ml | 41.25mg/ml | 96.28 mg/ml | 较强 |
分组 | 蛋鸡总数 | 体温 | 采食量 | 周产蛋量 | 周产蛋率 |
实验组 | 1000 | 正常 | 300kg | 6108 | 87.26% |
对照组1 | 1000 | 好转 | 240kg | 4560 | 65.14% |
对照组2 | 1000 | 下降 | 200kg | 2383 | 34.04% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041713.2A CN103816361B (zh) | 2014-01-29 | 2014-01-29 | 预防治疗禽流感的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041713.2A CN103816361B (zh) | 2014-01-29 | 2014-01-29 | 预防治疗禽流感的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103816361A true CN103816361A (zh) | 2014-05-28 |
CN103816361B CN103816361B (zh) | 2017-03-01 |
Family
ID=50751841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410041713.2A Active CN103816361B (zh) | 2014-01-29 | 2014-01-29 | 预防治疗禽流感的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103816361B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225113A (zh) * | 2014-06-24 | 2014-12-24 | 梁绍伟 | 一种用于治疗禽畜病毒性疾病的中草药方剂 |
CN104686799A (zh) * | 2015-01-29 | 2015-06-10 | 福建傲农生物科技集团有限公司 | 一种猪饲料微生态添加剂及其制备方法 |
CN105125991A (zh) * | 2015-07-10 | 2015-12-09 | 常州市禾香塑业有限公司 | 一种用于禽畜饲料的中药添加剂及其制备方法 |
CN105901381A (zh) * | 2016-04-26 | 2016-08-31 | 中国科学院近代物理研究所 | 一种防治禽流感的饲料添加剂及其制备方法 |
CN107594127A (zh) * | 2017-11-01 | 2018-01-19 | 黄业钧 | 一种用于预防禽流感病毒的中药饲料添加剂及其制备方法 |
CN109420046A (zh) * | 2017-08-25 | 2019-03-05 | 湖南民康生物技术研究所 | 一种中草药组方制备防治猪高热病药物的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101023997A (zh) * | 2007-03-28 | 2007-08-29 | 东北农业大学 | 抗禽流感病毒的中药及其制作方法 |
CN101332255A (zh) * | 2007-06-28 | 2008-12-31 | 保定冀中药业有限公司 | 一种预防禽流感的中药提取物及制备方法 |
-
2014
- 2014-01-29 CN CN201410041713.2A patent/CN103816361B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101023997A (zh) * | 2007-03-28 | 2007-08-29 | 东北农业大学 | 抗禽流感病毒的中药及其制作方法 |
CN101332255A (zh) * | 2007-06-28 | 2008-12-31 | 保定冀中药业有限公司 | 一种预防禽流感的中药提取物及制备方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225113A (zh) * | 2014-06-24 | 2014-12-24 | 梁绍伟 | 一种用于治疗禽畜病毒性疾病的中草药方剂 |
CN104686799A (zh) * | 2015-01-29 | 2015-06-10 | 福建傲农生物科技集团有限公司 | 一种猪饲料微生态添加剂及其制备方法 |
CN105125991A (zh) * | 2015-07-10 | 2015-12-09 | 常州市禾香塑业有限公司 | 一种用于禽畜饲料的中药添加剂及其制备方法 |
CN105901381A (zh) * | 2016-04-26 | 2016-08-31 | 中国科学院近代物理研究所 | 一种防治禽流感的饲料添加剂及其制备方法 |
CN109420046A (zh) * | 2017-08-25 | 2019-03-05 | 湖南民康生物技术研究所 | 一种中草药组方制备防治猪高热病药物的方法 |
CN107594127A (zh) * | 2017-11-01 | 2018-01-19 | 黄业钧 | 一种用于预防禽流感病毒的中药饲料添加剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103816361B (zh) | 2017-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102846866B (zh) | 一种用于防治猪圆环病毒病的中药组合物及其制备方法 | |
CN103816361B (zh) | 预防治疗禽流感的中药及其制备方法 | |
CN102451459A (zh) | 一种治疗鸡瘟的中药 | |
CN104887890A (zh) | 一种治疗雏鸡白痢的药物组合物及其制备方法 | |
CN104800660A (zh) | 一种治疗肺炎支原体肺炎的中药制剂及其制备方法 | |
CN104208393A (zh) | 一种用于防治鸡传染性支气管炎的中药组合物及其制备方法 | |
CN103638361B (zh) | 一种治疗咳嗽的药物及其制备方法 | |
CN104225236A (zh) | 一种治疗小儿肺热咳嗽的中草药组合物 | |
CN104001045A (zh) | 一种用于治疗犬肺炎的药物及其制备方法 | |
CN104474104A (zh) | 一种防治鸡传染性鼻炎的中药组合物及其制备方法 | |
CN105056078A (zh) | 一种治疗胃火炽盛牙痛口臭的中药组合物 | |
CN103623192B (zh) | 用于治疗猪蓝耳病的药物及其制备方法 | |
CN104208168B (zh) | 一种用于治疗家禽呼吸道感染的复方中药组合物及其制备方法 | |
CN105994984A (zh) | 一种防治禽流感的中药饲料添加剂 | |
CN105727036A (zh) | 一种用于防治鸡马立克氏病的中药组合物及其制备方法 | |
CN104888075A (zh) | 一种治疗鼻窦炎的中药片剂及其制备方法 | |
CN104983840A (zh) | 一种治疗鼻炎的中药组合物 | |
CN104800658A (zh) | 治疗鼻窦炎的中药制剂 | |
CN104257952A (zh) | 一种治疗鸡球虫病的中药组合物 | |
CN104068283A (zh) | 用于防治绵羊痘的饲料、中药组合物、制备方法及应用 | |
CN110946981A (zh) | 一种治疗多种疾病的中药组合物及其制备方法 | |
CN108815421A (zh) | 一种鼻炎药 | |
CN108524829A (zh) | 一种防治鸡马立克氏病的饲料添加剂 | |
CN108042774A (zh) | 一种用于治疗慢性肠炎的中药组合物 | |
CN106266211A (zh) | 一种用于治疗带状疱疹的汤剂药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine for preventing and treating avian influenza and preparation method thereof Effective date of registration: 20200313 Granted publication date: 20170301 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980000698 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210415 Granted publication date: 20170301 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980000698 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine for prevention and treatment of avian influenza and its preparation Effective date of registration: 20210420 Granted publication date: 20170301 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980002807 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: No. 6 Danyang Avenue, East District, Industrial Cluster District, Zhecheng County, Shangqiu City, Henan Province, 476000 Patentee after: Henan Zhongsheng Bioengineering Co.,Ltd. Address before: No. 19, 8th Floor, Building B, Rongyuan Square, North Section of Huayuan Road, Zhengzhou City, Henan Province, 450000 Patentee before: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230809 Granted publication date: 20170301 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: HENAN ZHONGSHENG ANIMAL PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980002807 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese Medicine for Prevention and Treatment of Avian Influenza and Its Preparation Method Effective date of registration: 20230811 Granted publication date: 20170301 Pledgee: Bank of China Limited by Share Ltd. Zhecheng branch Pledgor: Henan Zhongsheng Bioengineering Co.,Ltd. Registration number: Y2023980051698 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |